Werewolf Therapeutics (HOWL) Treasury Shares (2020 - 2024)
Werewolf Therapeutics (HOWL) posted quarterly Treasury Shares of $145000.0 for Q3 2024, down 54.26% year-over-year from $317000.0 in Q4 2023, and down 3.33% on a QoQ basis from $150000.0 in Q2 2024.
Werewolf Therapeutics (HOWL) Treasury Shares (2020 - 2024) Analysis & Trends
Werewolf Therapeutics has reported Treasury Shares for 5 years, with the latest figure at $145000.0 in Q3 2024.
- Treasury Shares for Q3 2024 came in at $145000.0, down 54.26% year-over-year; the trailing twelve-month figure through Sep 2024 was $145000.0 (down 54.26% YoY), and the FY2023 annual result was $361500.0, up 12.01% from the prior year.
- Treasury Shares eased to $145000.0 in Q3 2024, from $150000.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $80.2 million in Q4 2020 and troughed at $145000.0 in Q3 2024.
- A 5-year average of $24.8 million and a median of $323000.0 in 2023 frame the typical range for Treasury Shares.
- The largest YoY upside for Treasury Shares was 64.86% in 2021 against a maximum downside of 99.63% in 2021.
- A 5-year view of Treasury Shares shows it stood at $80.2 million in 2020, then plunged by 99.63% to $295000.0 in 2021, then grew by 9.4% to $322725.0 in 2022, then grew by 12.01% to $361500.0 in 2023, then plunged by 59.89% to $145000.0 in 2024.
- Per Business Quant data, the three most recent Treasury Shares figures were $145000.0 in Q3 2024, $150000.0 in Q2 2024, and $361500.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Werewolf Therapeutics | 43.94 Mn | 43.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 145,000.00 |
| Sep 30, 2024 | 145,000.00 |
| Jun 30, 2024 | 150,000.00 |
| Jun 30, 2024 | 150,000.00 |
| Mar 31, 2024 | 361,500.00 |
| Mar 31, 2024 | 361,500.00 |
| Dec 31, 2023 | 361,500.00 |
| Dec 31, 2023 | 361,500.00 |
| Mar 31, 2023 | 38,000.00 |
| Mar 31, 2023 | 38,000.00 |
| Dec 31, 2022 | 81,343.00 |
| Dec 31, 2022 | 81,343.00 |
| Sep 30, 2022 | 236,000.00 |
| Sep 30, 2022 | 236,000.00 |
| Dec 31, 2021 | 295,000.00 |
| Dec 31, 2021 | 295,000.00 |
| Mar 31, 2021 | 80.25 Mn |
| Mar 31, 2021 | 80.25 Mn |
| Dec 31, 2020 | 80.25 Mn |
| Dec 31, 2020 | 80.25 Mn |